LivaNova (LIVN) EBT Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.78% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 74.66% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.02% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 54.33% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 108.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.71% |
| Dec 31, 2025 | -51.07% |
| Sep 30, 2025 | -23.69% |
| Jun 30, 2025 | 54.34% |
| Mar 31, 2025 | -822.94% |
| Dec 31, 2024 | 159.90% |
| Sep 30, 2024 | 2,346.76% |
| Jun 30, 2024 | 308.88% |
| Mar 31, 2024 | -450.12% |
| Dec 31, 2023 | -1,574.76% |
| Sep 30, 2023 | 98.14% |
| Jun 30, 2023 | -72.21% |
| Mar 31, 2023 | 75.40% |
| Dec 31, 2022 | 378.00% |
| Sep 30, 2022 | -155.33% |
| Jun 30, 2022 | 136.17% |
| Mar 31, 2022 | 119.83% |
| Dec 31, 2021 | 99.24% |
| Sep 30, 2021 | -122.06% |
| Jun 30, 2021 | -142.51% |
| Mar 31, 2021 | -367.40% |
| Dec 31, 2020 | -97.38% |
| Sep 30, 2020 | -187.18% |
| Jun 30, 2020 | 39.07% |
| Mar 31, 2020 | 72.01% |
| Dec 31, 2019 | 45.29% |
| Sep 30, 2019 | 340.29% |
| Jun 30, 2019 | -289.51% |
| Mar 31, 2019 | -197.22% |
| Dec 31, 2018 | -3,639.26% |
| Sep 30, 2018 | -130.46% |
| Jun 30, 2018 | -70.24% |
| Mar 31, 2018 | 5.74% |
| Dec 31, 2017 | -64.74% |
| Sep 30, 2017 | 37.74% |
| Jun 30, 2017 | 201.47% |
| Mar 31, 2017 | 153.64% |
| Oct 18, 2015 | -200.95% |
| Apr 24, 2015 | -74.63% |